Innovative Solutions

Built to disrupt
women’s health.

From fertility to permanent contraception, we are creating the future of accessible, office-based women’s healthcare solutions.

Our solutions Investor Relations →

The Fertility Crisis

IVF is failing to address
the crisis in fertility.

In 2025, U.S. fertility rates dropped to another record low.

Too ExpensiveHigh cash pay requirement is insurmountable for most.
Fear of Surgery & DrugsHigh emotional toll prevents many women from pursuing.
Limited Access to Fertility CareToo few fertility centers and specialists restrict patient access.

“FemaSeed offers an accessible, patient-centered approach that may help many individuals begin care sooner and with less complexity, and we are pleased to make it available as an early step in treatment.” Dr. Angela SilberOB/GYN, Refuah Health Center, New York

Empowering Women Fertility Portfolio →

Earlier care wherever
women seek it.

Femasys is expanding access to earlier, more complete and affordable fertility care that can be delivered by a woman’s OB/GYN or fertility specialist.

From Diagnosis Hers & his diagnostics

To Treatment First-line insemination

What this means for OB/GYNs

OB/GYNs can now offer their existing patients an earlier, first-line fertility treatment—before referral to a fertility specialist.

“I am proud to be at the forefront of shifting fertility care into the OB/GYN setting with an approach that is easily integrated into clinical practice, well tolerated by patients, and operationally straightforward for staff, including in-office sperm preparation for use with FemaSeed.” Dr. Salvatore FinazzoDownriver OBGYN, Trenton, MI

Patient Spotlight

More women are looking
for options other than IVF.

“For us, the success rates were about the same as IVF for my age, so it gave us great hope knowing that we might get lucky trying something much more affordable and less invasive.”

Aslyn, 39 • Florida • FemaSeed patient, 2026

Read Aslyn’s full story at the Ribbon Box →

U.S. Portfolio Pipeline Permanent Birth Control →

Unique delivery platform technology.
Built to expand OB/GYN offerings.

Expanding women’s healthcare from first-line fertility solutions to the future of permanent birth control.

Non-surgical permanent birth control

Women deserve more than surgery for permanent contraception. FemBloc offers a minimally invasive approach with no implant left behind for a natural solution.

FemBloc.com →

In the U.S.: Enrolling in final pivotal trial for U.S. approval.
ClinicalTrials.gov ↗

Outside the U.S.: FemBloc is approved in Europe and other select countries. Femasys is strategically selecting highly qualified partners to expand access to FemBloc for women worldwide.
Partner Inquiry →

Information Highlights All News →